• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-Q filed by Solarmax Technology Inc.

    5/16/25 6:06:22 AM ET
    $SMXT
    Engineering & Construction
    Consumer Discretionary
    Get the next $SMXT alert in real time by email
    NT 10-Q 1 solarmax_nt10q.htm NT 10-Q solarmax_nt10q.htm

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 12b-25

     

    NOTIFICATION OF LATE FILING

     

    SEC FILE NUMBER: 001-41959

     

    (Check One):

    ☐ Form 10-K     ☐ Form 20-F     ☐ Form 11-K     ☒ Form 10-Q     ☐ Form 10-D     ☐ Form N-SAR

     

    ☐ Form N-CSR

     

    For period ended:

    March 31, 2025

     

    ☐

    Transition Report on Form 10-K

    ☐

    Transition Report on Form 20-F

    ☐

    Transition Report on Form 11-K

    ☐

    Transition Report on Form 10-Q

    ☐

    Transition Report on Form N-SAR

     

    For the transition period ended: ___________________________________________________

     

    Read Instruction (on back page) Before Preparing Form. Please Print or Type.

    Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

     

    If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:

     

    PART I-REGISTRANT INFORMATION

     

    SolarMax Technology Inc.

    Full Name of Registrant

     

    3080 12th Street

    Address of Principal Executive Office (Street and Number)

     

    Riverside, California 92507

    City, State and Zip Code

     

     

     

       

    PART II-RULE 12b-25(b) and (c)

     

    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

     

    ☒

    (a)

    The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

     

     

    (b)

    The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

     

     

    (c)

    The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

     

    PART III-NARRATIVE

     

    State below in reasonable detail the reasons why the Form 10-K could not be filed within the prescribed time period.

     

    SolarMax Technology, Inc. (the “Company”) is unable to file its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2025 (the “Form 10-Q”) within the prescribed time period due to extra lead time from the Company’s transition in its independent registered public accounting firm from Marcum LLP (“Marcum”) to CBIZ CPAs P.C. (“CBIZ”). On November 1, 2024, CBIZ acquired the attest business of Marcum.  On May 5, 2025 CBIZ was engaged as the Company’s independent registered public accounting firm.  The Company was not able to prepare the Form 10-Q without unreasonable effort or expense. The Company requires additional time to compile and process the information necessary for the completion of the Form 10-Q. The Company anticipates filing the Form 10-Q no later than 5 days after the original filing date.

     

    PART IV-OTHER INFORMATION

     

    (1)

    Name and telephone number of person to contact with regard to this notification.

     

     

    David Hsu

     

    (951) 300-0788

     

    (Name)

     

    (Telephone Number)

     

    (2)

    Have all other periodic reports required under Section 13 or 15(d) or the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s) .☒ Yes ☐ No

      

    (3)

    Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? ☒ Yes ☐ No

      

    If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reason why a reasonable estimate of the results cannot be made.

     

    Based on preliminary financial results, the Company expects to report a gross profit of approximately $1.4 million and a net loss of approximately $1.3 million on revenues of approximately $6.9 million for the three months ended March 31, 2025, as compared with a negative gross profit of approximately $0.5 million and a net loss of approximately $19.3 million on revenues of approximately $5.8 million for the three months ended March 31, 2024. All revenue for both periods was generated from the Company’s United States operations.

     

    The financial results presented above for the three months ended March 31, 2025 reflect preliminary estimates of the Company’s results of operations as of the date of the filing of the Form 12b-25. These estimates are subject to change upon the completion of the reporting process and review of the Company’s financial statements, and actual results may vary significantly from these estimates.

     

    Cautionary Note on Forward-Looking Statements

     

    This notification contains or may contain, among other things, certain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve significant risks and uncertainties. Such statements may include, without limitation, statements with respect to the Company’s plans, objectives, projections, expectations and intentions and other statements identified by words such as “projects,” “may,” “could,” “would,” “should,” “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans” or similar expressions. These statements are based upon the current beliefs and expectations of the Company’s management and are subject to significant risks and uncertainties, including those detailed in the sections “Cautionary Note Concerning Forward-Looking Statements, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 and in other filings subsequently made by the Company. Actual results may differ significantly from those set forth in the forward-looking statements. These forward-looking statements involve certain risks and uncertainties that are subject to change based on various factors (many of which are beyond the Company’s control). The Company does not intend to publicly update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws.

     

     
    2

     

       

    SolarMax Technology, Inc.

    (Name of Registrant as Specified in Charter)

     

    has caused this notification to be signed on its behalf by the undersigned heretofore duly authorized.

     

    Date: May 16, 2025

    By:

    /s/ David Hsu

     

     

    Name:

    David Hsu

     

     

    Title:

    Chief Executive Officer (Principal Executive Officer)

     

     

     
    3

     

    Get the next $SMXT alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $SMXT

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SMXT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Chen Wei Yuan claimed ownership of 1,757,670 shares (SEC Form 3)

      3 - SolarMax Technology, Inc. (0001519472) (Issuer)

      6/12/25 4:17:32 PM ET
      $SMXT
      Engineering & Construction
      Consumer Discretionary
    • SEC Form 3 filed by new insider Zhang Lei

      3 - SolarMax Technology, Inc. (0001519472) (Issuer)

      6/12/25 4:16:54 PM ET
      $SMXT
      Engineering & Construction
      Consumer Discretionary
    • New insider Hsu Bingwen David claimed ownership of 4,032,298 shares (SEC Form 3)

      3 - SolarMax Technology, Inc. (0001519472) (Issuer)

      2/14/25 2:18:52 PM ET
      $SMXT
      Engineering & Construction
      Consumer Discretionary

    $SMXT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SolarMax Technology Reports First Quarter 2025 Financial Results

      RIVERSIDE, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- SolarMax Technology, Inc. (Nasdaq SMXT) ("SolarMax" or the "Company"), an integrated solar energy company, today reported financial results for the quarter ended March 31, 2025. First Quarter 2025 Financial Highlights Revenue: $6.9 million, compared with $5.8 million in the first quarter of 2024.Gross profit: $1.4 million, compared with ($0.5) million in the first quarter of 2024.   Cost of revenues in the first quarter of 2024 included a one-time, non-cash stock-based compensation expense of $1.3 million.Total operating expense: $2.6 million, compared with $18.4 million in the first quarter of 2024. Operating expense in the first quart

      5/16/25 7:27:41 PM ET
      $SMXT
      Engineering & Construction
      Consumer Discretionary
    • SolarMax Technology Reports 2024 Financial Results

      RIVERSIDE, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- SolarMax Technology, Inc. (Nasdaq SMXT) ("SolarMax" or the "Company"), an integrated solar energy company, today reported financial results for the year ended December 31, 2024. 2024 Financial Highlights Revenue: $23.0 million, compared with $54.1 million in 2023.Gross profit: $2.3 million, compared with $11.1 million in 2023.   Cost of revenues in 2024 included a one-time, non-cash stock-based compensation expense of $1.3 million.Total operating expense: $35.4 million, which included a one-time, non-cash stock-based compensation expense of $17.2 million and a $7.5 million goodwill impairment relating to our China segment, compared wi

      3/31/25 5:45:00 PM ET
      $SMXT
      Engineering & Construction
      Consumer Discretionary
    • SolarMax Technology Signs MOU for 40-Megawatt Solar Farm in Georgia

      RIVERSIDE, Calif., Dec. 12, 2024 (GLOBE NEWSWIRE) -- SolarMax Technology, Inc. (Nasdaq SMXT) ("SolarMax" or the "Company"), an integrated solar energy company, has entered into a Memorandum of Understanding (MOU) with Sunelement Energy Inc., a domestic manufacturer of solar panels ("Sunelement"), for the installation of a solar power and battery project in East Dublin, Georgia. The proposed project contemplates an electricity grid-connected photovoltaic solar power facility with a total capacity of approximately 40 megawatts, coupled with a battery energy storage system of 150 megawatt-hours. SolarMax is to provide the engineering, procurement, and construction ("EPC") services in connect

      12/12/24 8:00:00 AM ET
      $SMXT
      Engineering & Construction
      Consumer Discretionary

    $SMXT
    SEC Filings

    See more
    • Solarmax Technology Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - SolarMax Technology, Inc. (0001519472) (Filer)

      5/16/25 9:10:55 PM ET
      $SMXT
      Engineering & Construction
      Consumer Discretionary
    • SEC Form 10-Q filed by Solarmax Technology Inc.

      10-Q - SolarMax Technology, Inc. (0001519472) (Filer)

      5/16/25 4:03:14 PM ET
      $SMXT
      Engineering & Construction
      Consumer Discretionary
    • SEC Form NT 10-Q filed by Solarmax Technology Inc.

      NT 10-Q - SolarMax Technology, Inc. (0001519472) (Filer)

      5/16/25 6:06:22 AM ET
      $SMXT
      Engineering & Construction
      Consumer Discretionary

    $SMXT
    Financials

    Live finance-specific insights

    See more
    • OKYO Pharma and SolarMax Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

      ORLANDO, FL / ACCESSWIRE / August 23, 2024 / RedChip Companies will air interviews with OKYO Pharma Ltd. (NASDAQ:OKYO) and SolarMax Technology, Inc. (NASDAQ:SMXT) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, August 24, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:OKYO Pharma: https://www.redchip.com/assets/access/okyo_accessSolarMax: https://www.redchip.com/assets/access/smxt_accessIn an exclusive interview, Gary S. Jacob, PhD, CEO of OKYO Pharma, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to provide a corporate upd

      8/23/24 9:00:00 AM ET
      $OKYO
      $SMXT
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
      Engineering & Construction
      Consumer Discretionary